Ozempic is NOT Available in Tablet Form
Ozempic (semaglutide) is only available as a subcutaneous injection, not as tablets. The brand name Ozempic specifically refers to the injectable formulation administered once weekly 1.
Available Formulations of Semaglutide
Injectable Semaglutide (Ozempic)
- Route: Subcutaneous injection only
- Frequency: Once weekly
- Doses: 0.25 mg, 0.5 mg, and 1 mg per injection 1
- FDA-approved indications:
- Improving glycemic control in adults with type 2 diabetes
- Reducing major cardiovascular events (heart attack, stroke, cardiovascular death) in adults with type 2 diabetes and established cardiovascular disease 1
Oral Semaglutide (Rybelsus)
While there IS an oral formulation of semaglutide, it is marketed under a different brand name: Rybelsus (not Ozempic) 2, 3.
- Route: Oral tablet
- Doses: 3 mg, 7 mg, and 14 mg daily 2
- FDA-approved indication: Glucose lowering in type 2 diabetes only 4
- NOT approved for: Weight management or obesity treatment 4
- Special administration requirements: Must be taken with no more than 120 mL of plain water on an empty stomach, at least 30 minutes before any food, beverages, or other medications 2, 5, 6
Key Clinical Distinctions
For Type 2 Diabetes:
- Both injectable Ozempic and oral Rybelsus are approved 7, 2, 8
- Injectable semaglutide (Ozempic) has proven cardiovascular benefits 3
- Oral semaglutide demonstrated cardiovascular safety but not superiority in PIONEER-6 trial 3
For Weight Management:
- Injectable semaglutide at 2.4 mg weekly (brand name Wegovy, not Ozempic) is FDA-approved for obesity 9, 4, 10
- Oral semaglutide is NOT FDA-approved for weight management 4
Common Pitfall to Avoid
Do not confuse "oral semaglutide" with "Ozempic tablets"—they are not the same product. Ozempic refers exclusively to the injectable formulation. If a patient requests or asks about oral semaglutide, the correct medication name is Rybelsus, and it is only indicated for diabetes management, not weight loss 5, 6, 11.